ID   NCOR1_RAT               Reviewed;         533 AA.
AC   Q9WUB5; O70463;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   24-JUL-2024, entry version 148.
DE   RecName: Full=Nuclear receptor corepressor 1;
DE            Short=N-CoR;
DE            Short=N-CoR1;
DE   Flags: Fragment;
GN   Name=Ncor1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10441327; DOI=10.1093/hmg/8.9.1647;
RA   Boutell J.M., Thomas P., Neal J.W., Weston V.J., Duce J., Harper P.S.,
RA   Jones A.L.;
RT   "Aberrant interactions of transcriptional repressor proteins with the
RT   Huntington's disease gene product, huntingtin.";
RL   Hum. Mol. Genet. 8:1647-1655(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 476-528.
RC   TISSUE=Skeletal muscle;
RX   PubMed=10491148; DOI=10.1046/j.1432-1327.1999.00706.x;
RA   Schuler M.J., Buehler S., Pette D.;
RT   "Effects of contractile activity and hypothyroidism on nuclear hormone
RT   receptor mRNA isoforms in rat skeletal muscle.";
RL   Eur. J. Biochem. 264:982-988(1999).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-73; SER-196; SER-214;
RP   SER-230; SER-245; SER-529 AND SER-531, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Mediates transcriptional repression by certain nuclear
CC       receptors. Part of a complex which promotes histone deacetylation and
CC       the formation of repressive chromatin structures which may impede the
CC       access of basal transcription factors. Participates in the
CC       transcriptional repressor activity produced by BCL6. Recruited by
CC       ZBTB7A to the androgen response elements/ARE on target genes,
CC       negatively regulates androgen receptor signaling and androgen-induced
CC       cell proliferation (By similarity). Mediates the NR1D1-dependent
CC       repression and circadian regulation of TSHB expression (By similarity).
CC       The NCOR1-HDAC3 complex regulates the circadian expression of the core
CC       clock gene ARTNL/BMAL1 and the genes involved in lipid metabolism in
CC       the liver (By similarity). {ECO:0000250|UniProtKB:O75376,
CC       ECO:0000250|UniProtKB:Q60974}.
CC   -!- SUBUNIT: Forms a large corepressor complex that contains SIN3A/B and
CC       histone deacetylases HDAC1 and HDAC2. This complex associates with the
CC       thyroid receptor (TR) and the retinoid acid receptor (RAR) in the
CC       absence of ligand. Interacts directly with RARA; the interaction is
CC       facilitated with RARA trimethylation. Component of the N-Cor repressor
CC       complex, at least composed of CBFA2T3, HEXIM1, NCOR1, NCOR2, HDAC3,
CC       TBL1X, TBL1XR1, CORO2A and GPS2. Interacts with ZBTB33; the interaction
CC       serves to recruit the N-CoR complex to promoter regions containing
CC       methylated CpG dinucleotides. Interacts with TRIM28 and KDM3A.
CC       Interacts (via the RD1 domain) with BAZ1A (via its N-terminal); the
CC       interaction corepresses a number of NCOR1-regulated genes. Interacts
CC       with BCL6, C1D, DACH1, HEXIM1, HDAC7, RORA, RORC, SAP30, SIAH2, SIN3A
CC       and SIN3B. May interact with DEAF1. Interacts with RXRA. Interacts with
CC       SETD5. Interacts with VDR. Interacts with ZBTB7A (By similarity).
CC       Interacts with AR (By similarity). Interacts with HDAC3 (By
CC       similarity). {ECO:0000250|UniProtKB:O75376,
CC       ECO:0000250|UniProtKB:Q60974}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- DOMAIN: The N-terminal region contains three independent domains that
CC       are capable of mediating transcriptional repression (RD1, RD2 and RD3).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The C-terminal region contains two separate nuclear receptor-
CC       interacting domains (ID1 and ID2), each of which contains a conserved
CC       sequence referred to as the CORNR box. This motif is necessary and
CC       sufficient for binding to unligated nuclear hormone receptors, while
CC       sequences flanking the CORNR box determine the precise nuclear hormone
CC       receptor specificity (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated; mediated by SIAH2 and leading to its subsequent
CC       proteasomal degradation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the N-CoR nuclear receptor corepressors family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF124821; AAD32566.1; -; mRNA.
DR   EMBL; AF059311; AAC14567.1; -; mRNA.
DR   AlphaFoldDB; Q9WUB5; -.
DR   STRING; 10116.ENSRNOP00000072175; -.
DR   iPTMnet; Q9WUB5; -.
DR   PeptideAtlas; Q9WUB5; -.
DR   UCSC; RGD:3612; rat.
DR   AGR; RGD:3612; -.
DR   RGD; 3612; Ncor1.
DR   InParanoid; Q9WUB5; -.
DR   PhylomeDB; Q9WUB5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0000118; C:histone deacetylase complex; ISO:RGD.
DR   GO; GO:0072686; C:mitotic spindle; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0017053; C:transcription repressor complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:RGD.
DR   GO; GO:0035033; F:histone deacetylase regulator activity; ISO:RGD.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; IPI:RGD.
DR   GO; GO:0016922; F:nuclear receptor binding; ISO:RGD.
DR   GO; GO:0042974; F:nuclear retinoic acid receptor binding; IPI:RGD.
DR   GO; GO:0046965; F:nuclear retinoid X receptor binding; IPI:RGD.
DR   GO; GO:0046966; F:nuclear thyroid hormone receptor binding; ISO:RGD.
DR   GO; GO:0042975; F:peroxisome proliferator activated receptor binding; IPI:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0002361; P:CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; ISO:RGD.
DR   GO; GO:1904017; P:cellular response to Thyroglobulin triiodothyronine; ISO:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISO:RGD.
DR   GO; GO:0060318; P:definitive erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0008544; P:epidermis development; ISO:RGD.
DR   GO; GO:0061436; P:establishment of skin barrier; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0007595; P:lactation; IEP:RGD.
DR   GO; GO:0045475; P:locomotor rhythm; ISS:UniProtKB.
DR   GO; GO:0060766; P:negative regulation of androgen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IMP:RGD.
DR   GO; GO:0045922; P:negative regulation of fatty acid metabolic process; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:RGD.
DR   GO; GO:0045820; P:negative regulation of glycolytic process; ISO:RGD.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; ISO:RGD.
DR   GO; GO:1902894; P:negative regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0002155; P:regulation of thyroid hormone mediated signaling pathway; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEP:RGD.
DR   GO; GO:0051225; P:spindle assembly; ISO:RGD.
DR   GO; GO:0033077; P:T cell differentiation in thymus; ISO:RGD.
DR   GO; GO:0021794; P:thalamus development; ISO:RGD.
DR   InterPro; IPR051571; N-CoR_corepressor.
DR   PANTHER; PTHR13992; NUCLEAR RECEPTOR CO-REPRESSOR RELATED NCOR; 1.
DR   PANTHER; PTHR13992:SF5; NUCLEAR RECEPTOR COREPRESSOR 1; 1.
PE   1: Evidence at protein level;
KW   Biological rhythms; Chromatin regulator; DNA-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           <1..533
FT                   /note="Nuclear receptor corepressor 1"
FT                   /id="PRO_0000055619"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          37..144
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          130..209
FT                   /note="ID1"
FT                   /evidence="ECO:0000250"
FT   REGION          145..148
FT                   /note="Required for interaction with RARA in the absence of
FT                   its ligand"
FT                   /evidence="ECO:0000250"
FT   REGION          165..254
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          306..367
FT                   /note="ID2"
FT                   /evidence="ECO:0000250"
FT   REGION          382..476
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           29..33
FT                   /note="CORNR box 1"
FT   MOTIF           153..157
FT                   /note="CORNR box 2"
FT   MOTIF           357..361
FT                   /note="CORNR box 3"
FT   COMPBIAS        1..19
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        89..121
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        165..207
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        222..236
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        418..454
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         73
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         77
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75376"
FT   MOD_RES         196
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         230
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         245
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         278
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75376"
FT   MOD_RES         492
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O75376"
FT   MOD_RES         529
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         531
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        484
FT                   /note="R -> W (in Ref. 2; AAC14567)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        497
FT                   /note="A -> V (in Ref. 2; AAC14567)"
FT                   /evidence="ECO:0000305"
FT   NON_TER         1
SQ   SEQUENCE   533 AA;  57795 MW;  7DF60F8228227EC2 CRC64;
     KDKGPPPKSR YEEELRTRGK TTITAANFID VIITRQIASD KDARERGSQS SDSSSSLSSH
     RYEAPSDAIE VISPASSPAP PQEKPQTYQP EMVKANQAEN ESPQQYEGPL THYRSQQGSP
     SPQQQPPLPP SSQAEGMGQV PRTHRLITLA DHICQIITQD FARNQVPSQP STSTFQTSPS
     ALSSTPVRTK PSSRYSPESQ SQTVLHPRPG PRVSPENLVD KSRGSRPGKS PERSHIPSEP
     YEPISPPQGP AVHEKQDSML LLSQRGMDPA EQRSDSRSPG SISYLPYFFT KLESTSPMVK
     SKKQEIFRKL NSSGGGDSDM AAAQPGTEIF NLPAVTTSGA VSSRSHSFAD PASNLGLEDI
     IRKALMGSFD DKVEDHGVVM PHPVGVVPGS ASTSVVTSSE TRRDEGDPSP HSGVCKPKLI
     NKSNSRKSKS PIPGQNYLGT ERPSSVSSVH SEGDYHRQTP GWAWEDRPSS TGSTQFPYNP
     LTIRMLSSTP PTPIACAPSA ITQAAPHQQS RIWEREPAPL LSAQYETLSD SDD
//
